catechin and Lymphoma, Non-Hodgkin

catechin has been researched along with Lymphoma, Non-Hodgkin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jalili, A; Janowska-Wieczorek, A; Korol, C; Lee, H; Marquez-Curtis, L; Qiu, Y; Ratajczak, MZ; Shirvaikar, N; Turner, AR1
Hazawa, M; Kashiwakura, I; Sugata, S; Takahashi, K1
Cerhan, JR; Cozen, W; Davis, S; Frankenfeld, CL; Hartge, P; Morton, LM; Schenk, M; Ward, MH1

Other Studies

3 other study(ies) available for catechin and Lymphoma, Non-Hodgkin

ArticleYear
Fifth complement cascade protein (C5) cleavage fragments disrupt the SDF-1/CXCR4 axis: further evidence that innate immunity orchestrates the mobilization of hematopoietic stem/progenitor cells.
    Experimental hematology, 2010, Volume: 38, Issue:4

    Topics: Animals; Catechin; Cells, Cultured; Chemokine CXCL12; Chemotaxis; Complement C5; Complement C5a; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Expression Regulation; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Immunity, Innate; Lymphoma, Non-Hodgkin; Mice; Peptide Fragments; Receptor, Anaphylatoxin C5a; Receptors, CXCR4; Up-Regulation

2010
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
    Journal of natural products, 2011, Apr-25, Volume: 74, Issue:4

    Topics: Apoptosis; Caspase 3; Catechin; HL-60 Cells; Humans; K562 Cells; Lymphoma, Non-Hodgkin; Molecular Structure; Reactive Oxygen Species; Receptors, Laminin; Stereoisomerism

2011
Dietary flavonoid intake and non-Hodgkin lymphoma risk.
    The American journal of clinical nutrition, 2008, Volume: 87, Issue:5

    Topics: Adult; Aged; Anthocyanins; Anticarcinogenic Agents; Antioxidants; Catechin; Diet; Diet Surveys; Dose-Response Relationship, Drug; Female; Flavonoids; Flavonols; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Population Surveillance; Proanthocyanidins; Registries; Risk Factors; SEER Program; United States

2008